Physician profile
Eric D Aitken
NPI 1083731145
$5,018.81
in general payments reported to CMS, 2019-2025
48 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $341 · 2021: $1,544 · 2022: $873 · 2023: $703 · 2024: $518 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,289.96 | 2019-2025 | Botox, Ubrelvy, Qulipta |
| Collegium Pharmaceutical, INC. | $298.66 | 2019-2025 | Xtampza, Belbuca |
| Avanir Pharmaceuticals, INC. | $278.90 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $246.48 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $216.68 | 2022-2024 | Rexulti, Nuedexta |
| E.R. Squibb & Sons, L.L.C. | $201.46 | 2019-2022 | |
| Ossur Americas, INC. | $199.43 | 2024 | |
| Allergan, INC. | $194.03 | 2019-2022 | |
| Amgen INC. | $175.41 | 2019-2024 | Otezla, Enbrel, Prolia |
| Radius Health, INC. | $138.91 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $124.97 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $116.99 | 2019-2025 | Dysport |
| Pfizer INC. | $110.19 | 2019-2023 | |
| Protega Pharmaceutials INC | $98.38 | 2023 | Roxybond |
| Eisai INC. | $98.28 | 2020-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Aitken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.